IDEC Pharmaceuticals
San Diego, California, United States
About IDEC Pharmaceuticals
IDEC Pharmaceuticals develop therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases. Idec Pharmaceuticals was founded in 1986 by UC-San Diego physician and immunologist Ivor Royston, San Diego bioentrepreneur Howard Birndorf, and Stanford University cancer researchers Ron Levy and Richard Miller. In 2003, Idec Pharmaceuticals was merged with Biogen.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: Less than $1M
- Funding stage: M&A
- Last round: Series Unknown (Jan 1986)
- Website: idecpharm.com
- Phone: 617-679-2000
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/idec-pharmaceuticals-2458046 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.